Volume 16, Issue 2
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645



Three lines of were made highly resistant to cycloguanil hydrochloride, 4,4′-diaminodiphenylsulfone (DDS), or chloroquine diphosphate by the repeated treatment of infected mice with partially suppressive doses. They were then maintained on constant doses of the drugs to favor a fixed degree of resistance. Collectively, the three lines were resistant to the major types of suppressive antimalarial drugs.

Fourteen drugs were tested systematically for suppressive effects against these lines in parallel with the parent strain. The response of the lines to various heterologous drugs ranged from strong cross-resistance to hypersensitivity.

The composite results indicated the following grouping of the drugs: I: cycloguanil hydrochloride, chlorguanide, and pyrimethamine; II: DDS and sulfadiazine; III: chloroquine, amodiaquine, amopyroquine, acridine N-oxide CI-423, quinacrine, naphthalene BW 377-C54, and quinine; IV: primaquine; and V: oxophenarsine.

The data suggest possible alternative drugs for dealing with various types of resistant strains. They also may serve in drug development as a basis for recognizing compounds with new modes of action.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error